TEVA's Prolia Biosimilar Gets FDA Nod, Xolair Filing Accepted

Teva wins FDA approval for Prolia biosimilar Ponlimsi and secures Xolair biosimilar filing review by the FDA and EMA, strengthening its biosimilars push.